Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
Cellier C, Sahmoud T, Froguel E, Adenis A, Belaiche J, Bretagne JF, Florent C, Bouvry M, Mary JY, Modigliani R. Cellier C, et al. Among authors: modigliani r. Gut. 1994 Feb;35(2):231-5. doi: 10.1136/gut.35.2.231. Gut. 1994. PMID: 7508411 Free PMC article.
[Maintenance treatment of Crohn's disease using orally administered mesalazine (Pentasa). A controlled multicenter study. The Study Groups on the Treatment of Inflammatory Digestive Disorders].
Gendre JP, Mary JY, Florent C, Modigliani R, Colombel JF, Soulé JC, Galmiche JP, Lerebours E, Descos L, Viteau JM, et al. Gendre JP, et al. Among authors: modigliani r. Ann Gastroenterol Hepatol (Paris). 1993 Oct;29(5):251-6. Ann Gastroenterol Hepatol (Paris). 1993. PMID: 8250520 Clinical Trial. French.
Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
Gendre JP, Mary JY, Florent C, Modigliani R, Colombel JF, Soulé JC, Galmiche JP, Lerebours E, Descos L, Viteau JM, et al. Gendre JP, et al. Among authors: modigliani r. Gastroenterology. 1993 Feb;104(2):435-9. doi: 10.1016/0016-5085(93)90411-5. Gastroenterology. 1993. PMID: 8425685 Clinical Trial.
Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
Modigliani R, Colombel JF, Dupas JL, Dapoigny M, Costil V, Veyrac M, Duclos B, Soulé JC, Gendre JP, Galmiche JP, Danne O, Cadiot G, Lamouliatte H, Belaïche J, Mary JY. Modigliani R, et al. Gastroenterology. 1996 Mar;110(3):688-93. doi: 10.1053/gast.1996.v110.pm8608877. Gastroenterology. 1996. PMID: 8608877 Clinical Trial.
Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
Florent C, Cortot A, Quandale P, Sahmound T, Modigliani R, Sarfaty E, Valleur P, Dupas JL, Daurat M, Faucheron JL, Lerebours E, Michot F, Belaiche J, Jacquet N, Soulé JC, Rothman N, Gendre JP, Malafosse M. Florent C, et al. Among authors: modigliani r. Eur J Gastroenterol Hepatol. 1996 Mar;8(3):229-33. doi: 10.1097/00042737-199603000-00008. Eur J Gastroenterol Hepatol. 1996. PMID: 8724022 Clinical Trial.
A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine.
Lémann M, Mary JY, Colombel JF, Duclos B, Soule JC, Lerebours E, Modigliani R, Bouhnik Y; Groupe D'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif. Lémann M, et al. Among authors: modigliani r. Gastroenterology. 2005 Jun;128(7):1812-8. doi: 10.1053/j.gastro.2005.03.031. Gastroenterology. 2005. PMID: 15940616 Clinical Trial.
192 results